Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Clinical trial NCT07193615 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07193615
- Sponsor
- RenJi Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-18
- Primary completion
- 2027-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.